Publicly funded vaccines
This web page has moved. The new web page is available here.
Last updated: September 14, 2023
This information is for health professionals.
On this page: Flu vaccine claims (2023-2024) | COVID-19 vaccine | Publicly funded vaccine PINs
PharmaCare pays a fee when an authorized pharmacist, and in some cases non-pharmacist, administers a publicly funded vaccine to eligible B.C. residents. The fee for most publicly funded vaccines is $12.10. The fee for the COVID-19 vaccine is $18.00.
Key details:
- Enter COVID-19 and publicly funded influenza vaccinations in ImmsBC only
- Enter all other vaccinations in PharmaNet
- Vaccine administrations must be entered on the day of the vaccination
- Record the lot number for every vaccine administered, in case of rare events such as a vaccine recall or an adverse event following immunization (AEFI). For PharmaNet entries, record the lot number the SIG field
Refer to the BCCDC’s B.C. Immunization Manual for criteria, immunization schedule and other important information.
Non-pharmacist vaccine administration
PharmaCare allows pharmacies to claim the administration fee if a contracted nurse administers an influenza or COVID-19 vaccine.
Any nurse administering an influenza or COVID-19 vaccine in a B.C. pharmacy must be:
- Licensed by the B.C. College of Nurses and Midwives (BCCNM); i.e., they must be an active registrant of that college (LPNs, NPs, RNs, and RPNs), OR
- Permitted under the November 4, 2022, Provincial Health Officer order, as student nurses or retired nurses, with supervision as per the PHO order
Flu vaccines can be administered by a pharmacy technician or pharmacy student, as authorized under the November 4, 2022, PHO, but must be supervised by a college registrant authorized under a health profession regulation.
How to claim publicly funded vaccines
Refer to COVID-19 claims and flu vaccine claims for procedures for those vaccines.
If administered to eligible patients for publicly funded vaccines:
- Use the appropriate PIN in PharmaNet
- Enter the quantity as the fluid volume of the vaccine (e.g. 0.5 mL)
- In SIG field, enter lot number and injection arm (RIGHT or LEFT) or “bilateral” for nasal spray, separated by an underscore _
- Do not enter a drug cost or fee
- Do not enter an intervention code
Patients who are not eligible:
- Dispense the vaccine ordered from your private supplier
- Enter the product’s DIN in PharmaNet
- In SIG field, enter lot number and injection arm (RIGHT or LEFT) or “bilateral” for nasal spray, separated by an underscore _
- Charge the patient directly
Flu vaccine claims (2023-2024)
Once the annual campaign has officially begun (Sep 1 - June 1), pharmacies may submit claims for flu vaccinations.
Publicly funded flu vaccines
- Record in ImmsBC
- Use the vaccine DIN
- Records will be shared with PharmaNet, allowing PharmaCare to process the claim
- Note that in ImmsBC, a drug use evaluation (DUE) does not automatically occur
The publicly funded flu vaccines for the 2023 – 2024 season are:
Private vaccine claims
Private supply vaccinations are eligible for PharmaCare’s drug administration fee of $11.41.
Three publicly funded flu vaccines are also available for private supply.
- If product is both private and public supply:
- Enter your CPBC ID in the Prescriber ID field and the PIN in PharmaNet:
- Flumist® Quadrivalent - PIN 66128276
- Fluzone® Quadrivalent - PIN 66128073
- Fluzone® High-Dose Quadrivalent - PIN 66127356
- In SIG field, enter lot number and injection arm (RIGHT or LEFT) or “bilateral” for nasal spray, separated by an underscore _
- Enter your CPBC ID in the Prescriber ID field and the PIN in PharmaNet:
- If product is uniquely private, enter the DIN in PharmaNet
COVID-19 vaccines
Enter COVID-19 vaccinations in ImmsBC only. Records will be shared with PharmaNet, allowing PharmaCare to process the claim.
- BC Immunization Manual, Part 4–Biological Products, COVID-19 vaccines
- COVID-19 Immunization Guide for B.C. Community Pharmacies
- BCCDC's COVID-19 vaccine screening checklist (PDF)—for informed-consent conversation with a client and a health assessment
| Vaccine product group | Brand | Vaccine product | PIN |
|---|---|---|---|
| COVID-19 | Vaxzevria Manufacturer: AstraZeneca |
COVID-19 vaccine (ChAdOx1-S [recombinant]) | 66127320 Applies to both 8-dose and 10-dose vials |
| COVID-19 | Comirnaty® Manufacturer: Pfizer-BioNTech |
COVID-19 vaccine (tozinameran) | 66127303 Applies to both 6-dose and 10-dose vials |
| COVID-19 | SPIKEVAX® Manufacturer: Moderna |
COVID-19 vaccine (elasomeran) | 66127304 |
Publicly funded vaccine PINs
| Vaccine product group | Vaccine product | PIN |
|---|---|---|
| Haemophilus b conjugate | Act-HIB® | 66128205 |
| Haemophilus influenzae type b conjugate | Hiberix® | 66128170 |
| Hepatitis A | Avaxim™ | 66124760 |
| Avaxim™ Pediatric | 66124831 | |
| Havrix® 1440 | 66124768 | |
| Havrix® Junior 720 | 66124769 | |
| Vaqta® Adult | 66124794 | |
| Vaqta® Pediatric | 66124795 | |
| Hepatitis B | Engerix® B | 66124764 |
| Engerix® B Pediatric | 66128130 | |
| Recombivax HB® | 66124789 | |
| Recombivax HB® Adult Dialysis | 66124790 | |
| Recombivax HB® Pediatric | 66124791 | |
| Human papillomavirus (2 strains) | Cervarix™ | 66127902 |
| Human papillomavirus (9 strains) | Gardasil® 9 | 66128117 |
| Measles, mumps, rubella | MMR-II™ | 66124781 |
| Priorix™ | 66124834 | |
| Measles, mumps, rubella, and varicella virus | Proquad® | 66128068 |
| Priorix-Tetra | 66128069 | |
| Meningococcal group B | Bexsero | 66128075 |
| Meningococcal C conjugate | Meningitec™ | 66124832 |
| Menjugate® | 66128114 | |
| Neis Vac-C® | 66124782 | |
| Pneumococcal conjugate 13-valent | Prevnar 13 | 66128070 |
| Pneumococcal 23-valent | Pneumovax® 23 | 66124785 |
| IPV (polio for travel indications) | Imovax® Polio | 66124773 |
| Quadrivalent meningococcal conjugate | Menveo | 66128071 |
| Menactra | 66128072 | |
| Nimenrix® | 66128152 | |
| Rabies | RabAvert® | 66124788 |
| Smallpox and Monkeypox | Imvamune® | 66128369 |
| Tetanus, diphtheria | Td Adsorbed | 66124793 |
| Tetanus, diphtheria, acellular pertussis | Adacel® | 66124758 |
| Boostrix® | 66127901 | |
| Tetanus, diphtheria, acellular pertussis, polio adsorbed | Quadracel® | 66124787 |
| Adacel® Polio | 66128131 | |
| Boostrix®-Polio | 66128094 | |
| Tetanus, diphtheria, acellular pertussis, polio, hepatitis B, haemophilus influenzae type b adsorbed | Infanrix hexa® | 66124776 |
| Tetanus, diphtheria, IPV (polio for travel indications) | Td Polio Adsorbed | 66124792 |
| Varicella | Varilrix® | 66124796 |
| Varivax® III | 66124797 |
Resources
Section 8.10 – Pharmacist administration of drugs and vaccines
